Rheumatoid arthritis

Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance

Semin Arthritis RheumPublished Systematic review and meta-epidemiological study of randomised trials

Pooled result · Treatment effect on global assessment (SMD vs placebo)Result — go to the resultΔSMDGlobal −0.09 95% CI −0.12 to −0.05

Authors' conclusion

Targeted therapies show larger improvements in physician-assessed outcomes than on patient-reported outcomes, largely driven by SJC. Pain remains a distinct determinant of patient assessments

Study context

Population
RA patients in double-blind randomised controlled trials (RCTs) comparing targeted therapies with placebo73 double-blind RCTs (165 comparisons)
Participants
33,956 patients
Comparison
Physician global assessment vs patient global assessment improvements with targeted therapies vs placebo
Outcome
Agreement between physician and patient global assessments: ΔSMD Global (SMD physician global assessment − SMD patient global assessment)
Methodological detailsmultivariate meta-analysis, multiple imputation, meta-regression
  • Multivariate meta-analysis
  • Multiple imputation
  • Meta-regression

Pooled result

As reported in the abstract

Treatment effect on global assessment (SMD vs placebo)

ΔSMDGlobal

−0.09

95% CI −0.12 to −0.05

By group

Physician global assessment

−0.60

SMD · 95% CI −0.65–-0.55

Patient global assessment

−0.50

SMD · 95% CI −0.54–-0.46

Physician global assessmentvs Patient global assessment
ΔSMDGlobal −0.09 (95% CI −0.12 to −0.05)

Further pooled results

Domain-level predictors (univariable meta-regression)

Disability, Tender joint count (TJC) and Swollen joint count (SJC) strongest associations of both assessments
SJC the only domain significantly associated with ΔSMDGlobal
Pain independently associated only with patient global assessment

Original publication

Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance. Semin Arthritis Rheum. Published 14 June 2026. doi:10.1016/j.semarthrit.2026.153023

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.